CureVac N.V. (FRA:5CV)
4.642
-0.098 (-2.07%)
Aug 1, 2025, 5:19 PM CET
CureVac Revenue
CureVac had revenue of 893.00K EUR in the quarter ending March 31, 2025, a decrease of -92.78%. This brings the company's revenue in the last twelve months to 523.70M, up 787.60% year-over-year. In the year 2024, CureVac had annual revenue of 535.18M with 895.54% growth.
Revenue (ttm)
523.70M
Revenue Growth
+787.60%
P/S Ratio
2.01
Revenue / Employee
579.31K
Employees
983
Market Cap
1.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 535.18M | 481.42M | 895.54% |
Dec 31, 2023 | 53.76M | -13.66M | -20.26% |
Dec 31, 2022 | 67.42M | -35.57M | -34.54% |
Dec 31, 2021 | 102.99M | 54.12M | 110.74% |
Dec 31, 2020 | 48.87M | 31.46M | 180.61% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.17B |
CureVac News
- 5 weeks ago - CureVac Announces Voting Results of General Meeting - Accesswire
- 5 weeks ago - CureVac's General Meeting: Key Voting Results Revealed! - Wallstreet:Online
- 5 weeks ago - EQS-News: CureVac Announces Voting Results of General Meeting - Wallstreet:Online
- 5 weeks ago - Amarin Lands Massive European Commercialization Deal For Heart Drug Vazkepa, Stock Surges - Benzinga
- 6 weeks ago - $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CureVac N.V. (NASDAQ: CVAC) - GlobeNewsWire
- 7 weeks ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of Shareholders - GlobeNewsWire
- 7 weeks ago - This Sherwin-Williams Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday - Benzinga
- 7 weeks ago - BioNTech's Acquisition Of CureVac Brings Complementary Method To Target Cancer - Seeking Alpha